Clinical trials: Vulvar Neoplasms

Squamous Cell Carcinoma

Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar

• Completed
• Age: 18 years and older
• Phase 2
• Results posted

In this research study we are looking to see how vulvar cancer responds to erlotinib therapy. Two distinct patient populations are targeted: women with locally advanced measurable squamous cell carcinoma of the vulva, primary or…

Trial name

NCT00476476

Testing

Erlotinib

Where

4 sites in United States

Volunteers

41 people

Sponsor

Dana-Farber Cancer Institute